Lauren Ford, APRN
Women's Health · Bossier City, LANPI 1235605163
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,090 and has fallen 52.6% since, to $516 in 2025. Among women's health clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$689
- Daiichi Sankyo Inc.$419
- Sumitomo Pharma America, Inc.$229
- Astellas Pharma US Inc$200
- Aspira Women's Health Inc$166
- Evofem Biosciences, Inc.$158
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,12797%
- Education$853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $689 |
| Daiichi Sankyo Inc. | 26 | $419 |
| Sumitomo Pharma America, Inc. | 12 | $229 |
| Astellas Pharma US Inc | 9 | $200 |
| Aspira Women's Health Inc | 2 | $166 |
| Evofem Biosciences, Inc. | 10 | $158 |
| Exeltis, USA Inc. | 10 | $151 |
| Pfizer | 9 | $142 |
| Davol Inc. | 2 | $120 |
| Myovant Sciences Inc. | 5 | $94 |
| Myriad Women's Health, Inc. | 2 | $92 |
| Dexcom, Inc. | 2 | $65 |
| Therapeuticsmd, Inc. | 4 | $60 |
| Sage Therapeutics, LLC | 3 | $59 |
| Amgen | 4 | $57 |
| Shield Therapeutics Inc | 3 | $54 |
| Lupin Inc. | 4 | $53 |
| Lilly USA, LLC | 3 | $49 |
| Novo Nordisk | 2 | $36 |
| Mayne Pharma Commercial LLC | 2 | $36 |
| Scynexis, Inc. | 2 | $35 |
| Organon | 4 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Vertex | 2 | $27 |
| Avion Pharmaceuticals | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Smith+Nephew | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Millicent US Inc | 1 | $17 |
| Merck | 1 | $13 |
How this compares
$3,212 in reported general payments places this provider in the 90th percentile of 128 women's health providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 29 | $1,397 |
Paid to pharmacies, not to this prescriber.
Other women's health in Bossier City
- Nancy WellsBossier City$47K
- Thresa CaughmanBossier City$3K
- Christina LeachBossier City$563
- Amanda HayesShreveport$51K
- Ann JoplingMonroe$16K
- Kendra Joseph-RodgersNew Orleans$10K
- Aundria CannonLafayette$5K
- Jordan ForsthoffLafayette$5K
- Jennifer MillerMonroe$4K
- Alysha HinsonShreveport$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.